Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
06/2007
06/12/2007US7230112 Process for making amide acetals
06/12/2007US7230009 Pyridoxal analogues and methods of treatment
06/12/2007US7230004 Cyclopamine analogues and methods of use thereof
06/12/2007US7229990 E.g., tert-Butyl-5-amino-2-methylthio-4-(3-methoxyphenyl)-quinazoline-6 -carboxamide; used in fertility regulation therapies.
06/12/2007US7229989 When used in photochromic eyeglass lenses, produce essentially blue color tones which have a high darkening capacity
06/07/2007WO2007064552A1 Process for preparing unsaturated imidoalkoxysilanes
06/07/2007WO2007063868A1 Arylmethylene urea derivative and use thereof
06/07/2007US20070129395 pure crystalline form of Temsirolimus (CCI-779)
06/07/2007US20070129394 Rapamycin conjugated to peptides of up to 10 amino acid units through a carbamate linkage at position 42; coated stents; restenosis, cancer, autoimmune, transplant rejection
06/07/2007US20070129393 1-(5-Chloro-1'H,3H-spiro[1-benzofuran-2,4'-piperidin]-1'-yl)-3-(2-methoxyphenoxy)propan-2-ol hydrochloride; modulators of chemokine receptor; autoinuune, inflammatory, porliferative diseases; antagonists
06/07/2007US20070129360 N2-Chlorocarbonyl-N4-(2,2-dimethyl-3-oxo-4H-5-pyrido[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine; kinase inhibitors; breast cancer; inhibiting signal transduction cascades in which Syk plays a role
06/07/2007US20070129252 2-Halo-6-alkylphenyl-substituted spirocyclic tetramic acid derivatives
06/07/2007CA2636314A1 Arylmethylene urea derivative and use thereof
06/07/2007CA2632227A1 5-(arylsulfonyl)-pyrazolopiperidines
06/06/2007EP1792904A1 Intermediate and process of preparation of ecteinascidin using such intermediate
06/06/2007EP1791846A1 An improved process for the preparation of irinotecan hydrochloride trihydrate
06/06/2007EP1791845A2 Furanopyridine derivatives as ack1 and lck modulators
06/06/2007EP1791816A1 Iodine-phenyl-substituted cyclic cetoenols
06/06/2007EP1791539A1 Process to prepare camptothecin derivatives
06/06/2007EP1427287B1 Pesticidal and parasitical di-and trifluorosubstituted alkene compounds
06/06/2007CN1976936A Tetrahydroquinolines
06/06/2007CN1976907A Heterocyclic amide compound and use thereof as an MMP-13 inhibitor
06/06/2007CN1976705A 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1H-pyrrolo not 2,3-C|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and dia
06/06/2007CN1974596A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
06/06/2007CN1974574A Novel tricyclic spiropiperidines or spiropyrrolidines
06/06/2007CN1319975C Camptothecin analogs and methods of preparation thereof
06/06/2007CN1319961C Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
06/06/2007CN1319929C Aryl phenyl substituted cyclic ketoenols
06/05/2007USRE39680 Sleep disorders associated with 5-HT2A serotonin receptor modulation; antagonists or agonists
06/05/2007USRE39679 Substituted heterocycle fused gamma-carbolines
06/05/2007US7227023 Quinoline 3-amino chroman derivatives
06/05/2007US7226938 Heterocyclic compounds
06/05/2007US7226929 drugs such as 6 -Chloro-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide, used as antithrombotic agents
06/05/2007US7226919 Compositions useful as inhibitors of protein kinases
06/05/2007CA2225528C Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
06/05/2007CA2157586C Indoletetralins having dopaminergic activity
05/2007
05/31/2007WO2007062342A1 Heterocyclic cetp inhibitors
05/31/2007WO2007062030A2 Quinuclidinone derivatives as anticancer agents
05/31/2007WO2007061978A1 Spirocyclic compounds as hdac inhibitors
05/31/2007WO2007061880A1 Spirocyclic compounds as hdac inhibitors
05/31/2007WO2007016525A3 Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
05/31/2007WO2006004937A3 Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders
05/31/2007US20070123705 Alkylation; serotonin receptor antagonists; depression, obsessive compulsive disorders, panic disorder, generalized anxiety disorder, social anxiety, sexual dysfunction, bulimia, obesity, addictive disorder
05/31/2007US20070123577 Inhibitor of protein modification products formation
05/31/2007US20070123557 side effects reduction; treating an obstructive disease of the respiratory tract or for treating overactive bladder; 3-oxa-9-azatricyclo(3.3.1.0(2,4)nonane derivatives
05/31/2007US20070123552 Method of manufacturing of 7-ethyl-10-hydroxycamptotecin
05/31/2007US20070123543 Novel compounds
05/31/2007US20070123532 Piperazine derivatives
05/31/2007US20070123530 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases
05/31/2007US20070123522 5-lipoxygenase-activating protein (flap) inhibitors
05/31/2007US20070123510 Guanidine derivatives
05/31/2007US20070123491 Podophyllotoxin derivatives as igf-1r inhibitors
05/31/2007US20070123421 Containing crystalline compounds which produce color when thermally converted to liquid or amorphous form time-independent
05/31/2007US20070122746 Thermal stability; coloring many different kinds of polymers
05/30/2007EP1790644A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
05/30/2007EP1789420A2 6H-[1]BENZOPYRANO[4,3-b]QUINOLINES AND THEIR USE AS ESTROGENIC AGENTS
05/30/2007EP1789419A1 Gyrase inhibitors and uses thereof
05/30/2007EP1427706B1 Substituted pyrazolo compounds for the treatment of inflammation
05/30/2007EP1318814B1 Triazole compounds useful as protein kinase inhibitors
05/30/2007EP1263723B1 Ningalin b analogs employable for reversing multidrug resistance
05/30/2007EP0819121B1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
05/30/2007CN1972949A Novel unsaturated tetracyclic tetrahydrofuran derivatives
05/30/2007CN1972938A 环状胺化合物 Cyclic amine compound
05/30/2007CN1972932A Compounds and methods for treating dyslipidemia
05/30/2007CN1318426C Novel cantharidimide and norcantharidimide derivant and its application in medicine
05/30/2007CN1318424C Aromatic heterocyclic carboxylic derivative, preparing method and use on medicine
05/29/2007US7223866 Imidazo[1,5-a]pyridine derivatives and methods for treating aldosterone mediated diseases
05/29/2007US7223779 Azasugar derivative and drug containing the same as the active ingredient
05/29/2007US7223776 Compounds with anti-bacterial activity
05/29/2007US7223771 Inhibit the secretion of gastric acid; methyl 2,3-dimethyl-9-(2-ethyl-6-methyl-phenyl)-7H-8,9-dihydro-pyrano[2,3-c]-imidazo[1,2-a]pyridine-6-carboxylate for example; gastrointestinal inflammatory diseases such as gastric ulcers; high selectivity of action, side effect reduction, good enteral activity
05/29/2007US7223770 Tocopherol-modified therapeutic drug compounds
05/29/2007US7223766 Bi-cyclic pyrimidine inhibitors of TGFβ
05/29/2007US7223738 Inhibitors of Akt activity
05/24/2007WO2007058392A1 Heterocyclic compound and medicinal application thereof
05/24/2007WO2007057775A1 Spiropiperidine derivatives
05/24/2007WO2007040650A3 Apoptosis promoters
05/24/2007US20070117889 Process for the direct preparation of pyrrolo[3,4-C]pyrroles
05/24/2007US20070117856 Indazole derivatives
05/24/2007US20070117843 Quinoline inhibitors of cGMP phosphodiesterase
05/24/2007US20070117832 Novel compound, corresponding compositons, preparation and/or treatment methods
05/24/2007US20070117823 N-sulfamoyl-N'-benzopyranpiperidine compounds and uses thereof
05/24/2007US20070117802 Met kinase inhibitors
05/24/2007US20070117799 Oxabispidine compounds useful in the treatment of cardiac arrhythmias
05/24/2007US20070117787 N-[(3R,5S)-1-(3-Acetoxy-2,2-dimethylpropyl)-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-acetyl]piperidine-4-acetic acid; in combination with a statin, lowering cholesterol-level and lowering triglyceride-level
05/24/2007US20070117211 Such as 4-amino-5-(N-methylamino)-2',7'-difluoro-3',6'-dihydroxy-spiro[isobenzofuran-1 (3H),9'-[9H]xanthen]-3-one for use as agents for measurement of nitrogen monoxide
05/23/2007EP1787992A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
05/23/2007EP1786812A1 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
05/23/2007EP1786772A1 Process for the scalable synthesis of 1, 3, 4, 9-tetrahydropyranoý3, 4-b¨-indole derivatives
05/23/2007CN1968951A Novel 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydroisoindol-l-one/5,6-dihydro-furo[2,3-c]pyrrol-4one derivatives ligands for alpha 7 nicotinic acetylcholine receptor
05/23/2007CN1966507A Benzopyran[4,3-b] indole compound, its preparation method and uses
05/23/2007CN1317282C Method for extracting protopine from decumbent corydalis tuber
05/22/2007US7220868 Process for the preparation of novel dyes for use in imaging members
05/22/2007US7220862 Calcitonin gene related peptide receptor antagonists
05/22/2007US7220860 Anticancer agents
05/22/2007US7220859 For use in therapy
05/22/2007US7220856 Substituted quinoline CCR5 receptor antagonists
05/22/2007US7220842 Immunoassays for buprenorphine and norbuprenorphine
05/22/2007US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis
05/22/2007US7220756 N-sulfonylheterocyclopyrrolyl-alkylamine compounds as 5-hydroxytryptamine-6 ligands
05/22/2007US7220738 Rifamycin analogs and uses thereof